ID1 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Deterioration of Clear Cell Renal Cell Carcinoma

Figure 4

Clinical manifestation of ccRCC patients with lowly- and highly expressed ID1 (cut-off value = 1.079).